NIM
NXG Investment Management’s Cytosorbents Corp CTSO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-11,464
| Closed | -$25K | – | 76 |
|
|
2022
Q2 | $25K | Sell |
11,464
-45,090
| -80% | -$98.3K | ﹤0.01% | 89 |
|
|
2022
Q1 | $180K | Buy |
56,554
+37,883
| +203% | +$121K | 0.02% | 93 |
|
|
2021
Q4 | $78K | Sell |
18,671
-102,208
| -85% | -$427K | 0.01% | 101 |
|
|
2021
Q3 | $982K | Buy |
120,879
+1,698
| +1% | +$13.8K | 0.1% | 69 |
|
|
2021
Q2 | $900K | Sell |
119,181
-1,114
| -0.9% | -$8.41K | 0.09% | 78 |
|
|
2021
Q1 | $1.04M | Buy |
120,295
+24,847
| +26% | +$216K | 0.12% | 77 |
|
|
2020
Q4 | $761K | Buy |
95,448
+34,435
| +56% | +$275K | 0.08% | 88 |
|
|
2020
Q3 | $487K | Buy |
61,013
+42,798
| +235% | +$342K | 0.07% | 83 |
|
|
2020
Q2 | $180K | Buy |
18,215
+8,199
| +82% | +$81K | 0.02% | 126 |
|
|
2020
Q1 | $77K | Sell |
10,016
-7,348
| -42% | -$56.5K | 0.01% | 108 |
|
|
2019
Q4 | $67K | Sell |
17,364
-53,479
| -75% | -$206K | ﹤0.01% | 128 |
|
|
2019
Q3 | $356K | Buy |
+70,843
| New | +$356K | 0.02% | 101 |
|